NCT01026493 2017-07-02Veliparib and Temozolomide in Treating Patients With Recurrent GlioblastomaRadiation Therapy Oncology GroupPhase 1/2 Completed257 enrolled 16 charts
NCT00946335 2014-07-09ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsNational Cancer Institute (NCI)Phase 1 Completed31 enrolled